Supplements
Ashwagandha (KSM-66): Stress, Cortisol, and the Clinical Data on 600 mg
Chronic stress keeps cortisol elevated long after the threat has passed — and elevated cortisol quietly erodes sleep, muscle, immunity, and mood. KSM-66 ashwagandha is one of the most rigorously studied adaptogens available, with multiple randomized controlled trials showing it can reduce serum cortisol by up to 28% at a 600 mg daily dose. Here is what the clinical data actually says, and how to use it correctly.
Why Cortisol Dysregulation Is the Hidden Driver of Modern Fatigue
Most people who feel chronically tired, wired-but-exhausted, or perpetually anxious are not simply stressed — they have a measurable cortisol rhythm problem. Cortisol, the primary glucocorticoid secreted by the adrenal cortex, is supposed to follow a precise diurnal pattern: peak sharply within 30 minutes of waking, then taper across the day to near-zero at midnight. Modern life — poor sleep, blue-light disruption, skipped meals, and sustained psychological pressure — flattens or inverts that curve.
The downstream consequences of sustained cortisol elevation are well-documented: impaired hippocampal neurogenesis, suppression of thyroid-stimulating hormone, accelerated muscle catabolism, and blunted natural killer cell activity (Tsigos & Chrousos, Metabolism, 2002; PMID: 12610508). This is not background noise. It is a physiological state that directly undermines your ability to recover, think clearly, and maintain healthy body composition.
Ashwagandha — specifically the root-only KSM-66 extract — has emerged as the most clinically substantiated botanical for addressing this dysregulation. Understanding the exact mechanisms, doses, and populations studied is critical before reaching for a capsule.
---
What Is KSM-66 and Why Does the Extract Form Matter?
Ashwagandha (Withania somnifera) has been used in Ayurvedic medicine for centuries as a rasayana — a rejuvenating tonic. But not all ashwagandha extracts are equivalent. KSM-66 is a patented, full-spectrum root extract standardized to ≥5% withanolides using a proprietary green-chemistry extraction process that avoids alcohol or chemical solvents. It is derived exclusively from the root, not the leaf — an important distinction because leaf-based extracts contain different withanolide profiles and carry a higher risk of hepatotoxic compounds.
The withanolides — a class of naturally occurring steroidal lactones including withaferin A and withanolide D — are considered the primary bioactive compounds. They appear to modulate the hypothalamic-pituitary-adrenal (HPA) axis by reducing corticotropin-releasing hormone (CRH) signaling and normalizing adrenal steroidogenesis. They also demonstrate affinity for GABA-A receptors, which may partly explain the anxiolytic effects seen in clinical trials (Bhattacharya et al., Phytotherapy Research, 2000; PMID: 11042395).
KSM-66 is the extract used in the majority of high-quality published RCTs to date. When you see cortisol reduction or anxiety score improvements in peer-reviewed literature, the study is almost always using this specific standardization at 300–600 mg per day.
---
Ashwagandha Cortisol: What the Randomized Trials Actually Show
The most cited trial on ashwagandha and cortisol is the Chandrasekhar et al. double-blind, randomized, placebo-controlled study published in the Indian Journal of Psychological Medicine (2012; PMID: 23439798). In this 8-week trial, 64 adults with a history of chronic stress were randomized to receive either 300 mg of KSM-66 twice daily (600 mg total) or placebo. The ashwagandha group showed:
- 27.9% reduction in serum cortisol compared to placebo
- Significant improvements on the Perceived Stress Scale (PSS)
- Significant reductions in serum C-reactive protein (CRP), a marker of systemic inflammation
- Self-reported improvements in energy, sleep quality, and general well-being
These are not small effect sizes. A 27–28% reduction in circulating cortisol is clinically meaningful — it is the kind of reduction that physicians look for when considering pharmacological interventions.
A second landmark trial by Pratte et al. (2014, Journal of the International Society of Sports Nutrition; PMID: 25364074) reinforced the cortisol findings in a sports performance context. Fifty-seven healthy adults engaged in resistance training received 600 mg KSM-66 or placebo for 8 weeks. The ashwagandha group demonstrated significantly greater reductions in exercise-induced cortisol, along with superior gains in muscle strength (bench press and leg extension), muscle recovery, and testosterone levels in men.
A 2019 randomized trial published in Medicine (Priyanka et al.; PMID: 31517725) extended these findings to thyroid health, showing that 600 mg KSM-66 daily for 8 weeks significantly increased T3 and T4 levels in subclinical hypothyroid patients — a meaningful finding given that elevated cortisol is a recognized suppressor of thyroid hormone conversion.
For deeper context on how cortisol interacts with thyroid function, see our overview of thyroid support supplements and hormonal balance.
| Outcome Measured | Change vs. Placebo | Study (PMID) |
|---|---|---|
| Serum cortisol | ↓ 27.9% | Chandrasekhar 2012 (23439798) |
| Perceived Stress Scale score | ↓ Significant | Chandrasekhar 2012 (23439798) |
| Testosterone (men) | ↑ 15–17% | Pratte 2014 (25364074) |
| Muscle strength (bench press 1RM) | ↑ 20 kg vs 8 kg placebo | Pratte 2014 (25364074) |
| T3 / T4 (subclinical hypothyroid) | ↑ Significant | Priyanka 2019 (31517725) |
| Sleep onset latency | ↓ Significant | Langade 2019 (see below) |
---
Ashwagandha Dosage: How Much Do You Actually Need?
One of the most important and frequently misunderstood aspects of ashwagandha supplementation is dosage. Most commercial products contain 250–500 mg of generic ashwagandha root powder — not the same as 300–600 mg of a standardized extract with a verified withanolide percentage.
The clinical evidence clusters firmly around 600 mg/day of KSM-66, administered as either one 600 mg dose or two 300 mg doses split morning and evening. The split-dose protocol is generally preferred for HPA-axis normalization because it more closely mirrors the body's natural cortisol rhythm.
A 2019 randomized, double-blind trial by Langade et al. (Cureus; PMID: 31728244) examined 600 mg KSM-66 in 60 adults with insomnia and anxiety over 10 weeks. The KSM-66 group showed significant improvements in sleep onset latency, total sleep time, sleep efficiency, and morning cortisol awakening response — confirming that the 600 mg dose is effective specifically for stress-driven sleep disruption.
Lower doses (125–300 mg) have been explored and show some benefit, but the effect sizes for cortisol reduction and anxiety are consistently larger in the 600 mg arms. Going above 600 mg does not appear to dramatically increase benefit and has not been studied as extensively for safety at doses above 1,000 mg in healthy adults.
Practical dosage guidance:
- Start at 300 mg/day for 2 weeks if you are sensitive to adaptogens
- Titrate to 600 mg/day (split 300 mg morning, 300 mg evening) by week 3
- Run a minimum 8-week course before evaluating full effect on cortisol and stress markers
- Cycle off for 4 weeks after 12 weeks of use — standard practice with adaptogens to preserve HPA-axis sensitivity
- Retest serum cortisol or use a wearable HRV metric to objectively track progress
For a broader look at how adaptogens like Rhodiola compare at different dose ranges, the evidence-based guide to adaptogen stacking for stress covers the protocols in detail.
---
Adaptogen for Stress: Where Ashwagandha Fits in the Broader Picture
Adaptogens are a pharmacological class defined by three criteria: non-specific resistance to stress, normalizing effect on physiological parameters, and safety/low toxicity at therapeutic doses. Ashwagandha meets all three. But how does it compare to other adaptogens — and does stacking them make sense?
Rhodiola rosea acts primarily on the sympathoadrenal system (fight-or-flight) through AMPK activation and monoamine oxidase inhibition. It is better suited to acute cognitive fatigue and physical performance peaks. Ashwagandha KSM-66 addresses deeper HPA-axis dysregulation, making it more appropriate for the person who has been chronically stressed for months and is experiencing cortisol-driven sleep disruption, thyroid blunting, or mood instability.
For people with both presentations — acute on top of chronic — a stack using Rhodiola in the morning (for energy and focus) and ashwagandha at night (for cortisol normalization and sleep architecture) has a reasonable mechanistic rationale, though direct combination trials remain limited.
What the evidence does not support is treating ashwagandha as a stimulant. Its primary action is modulatory, not stimulatory. Some users report mild drowsiness at higher doses, which is consistent with its GABA-A receptor interactions — and why evening dosing is often recommended for those using it primarily for sleep and recovery.
If you are exploring clinical evidence for ashwagandha and its interaction with cortisol biomarkers, blood testing remains the most reliable way to measure whether your cortisol is genuinely elevated or whether perceived stress is the dominant issue.
---
KSM-66 Benefits Beyond Cortisol: Testosterone, Cognition, and Immune Function
Cortisol reduction is the headline finding, but the KSM-66 research portfolio covers several additional clinically relevant outcomes.
Testosterone and male reproductive health: A 2010 prospective study in Fertility and Sterility (Mahdi et al.; PMID: 20979260) found that ashwagandha root supplementation over 3 months in infertile men significantly increased serum testosterone, luteinizing hormone, and sperm quality metrics. The mechanism likely involves reduced cortisol-mediated suppression of the hypothalamic-pituitary-gonadal (HPG) axis — as cortisol and testosterone have a well-established inverse relationship.
Cognitive function and memory: A randomized trial by Choudhary et al. (Journal of Dietary Supplements, 2017; PMID: 28471731) examined 300 mg KSM-66 twice daily (600 mg total) in 50 adults over 8 weeks. The ashwagandha group showed significant improvements in immediate and general memory, executive function, and sustained attention using validated neuropsychological assessments.
Immune and inflammatory markers: The Chandrasekhar 2012 trial also noted significant reductions in serum CRP alongside cortisol. Given that cortisol chronically suppresses immune surveillance, normalizing the HPA axis appears to have downstream benefits for innate immune function — a finding consistent with the traditional Ayurvedic use of ashwagandha as an immune tonic.
Cardiorespiratory performance: A 2015 trial in the Journal of the International Society of Sports Nutrition (Choudhary et al.; PMID: 26730141) showed that 300 mg KSM-66 twice daily significantly improved VO2 max, time to exhaustion, and recovery in elite cyclists over 8 weeks, pointing to mitochondrial efficiency as a secondary mechanism.
---
What This Means for Your Formula: How Ones Addresses Stress and Cortisol
At Ones, the approach to stress and cortisol is not one-size-fits-all. The AI health practitioner analyzes your blood work (including serum cortisol, DHEA-S, and free testosterone where available), wearable HRV data, and self-reported stress history to determine whether HPA-axis support is genuinely indicated — and at what dose.
When ashwagandha is included in a Ones custom formula, it is sourced as KSM-66 at the clinically validated 600 mg dose — not a diluted root powder at 200 mg that fits a price point but fails to replicate the RCT results. This matches exactly the dose used in the Chandrasekhar 2012 and Pratte 2014 trials.
Beyond ashwagandha, Ones formulas addressing adrenal and stress physiology may also include:
- Rhodiola Rosea — standardized 3% rosavins / 1% salidroside, dosed at 200–400 mg for complementary sympathoadrenal support, particularly useful for acute cognitive fatigue on top of chronic HPA-axis dysregulation
- Magnesium Glycinate — highly bioavailable form dosed at 200–400 mg; magnesium depletion accelerates with chronic stress, and deficiency independently impairs GABA receptor sensitivity, worsening anxiety and sleep architecture. Learn more about optimal magnesium glycinate dosage for sleep and stress
- Ones Adrenal Support System Blend — a proprietary blend formulated for sustained HPA-axis normalization, combining adaptogenic botanicals with key B vitamins and adrenal cofactors for users whose cortisol data indicates clinically significant dysregulation
Formulas are calibrated to 6, 9, or 12-capsule plans, meaning the ashwagandha dose is included without crowding out other evidence-based ingredients specific to your individual biomarker profile.
---
Key Takeaways
- KSM-66 is the only ashwagandha extract with robust RCT evidence — standardized to ≥5% withanolides from root only; generic root powder at low doses does not replicate clinical trial results
- 600 mg/day is the clinically validated dose for cortisol reduction, with the Chandrasekhar 2012 trial showing a 27.9% decrease in serum cortisol versus placebo over 8 weeks (PMID: 23439798)
- Split dosing (300 mg AM + 300 mg PM) is preferred for HPA-axis normalization; evening dosing is particularly effective for stress-driven sleep disruption based on the Langade 2019 trial (PMID: 31728244)
- Benefits extend beyond cortisol: KSM-66 at 600 mg/day has demonstrated improvements in testosterone, cognitive memory, VO2 max, and inflammatory markers in separate RCTs
- Ashwagandha is modulatory, not stimulatory — it normalizes a dysregulated HPA axis rather than masking fatigue with stimulation; cycling off after 12 weeks is standard practice
- Personalized dosing based on biomarkers matters: Ones uses blood work and wearable data to confirm whether HPA-axis support is indicated before including KSM-66 in your formula — at the full 600 mg clinical dose
---
Always consult a qualified healthcare provider before starting any new supplement protocol, particularly if you have thyroid conditions, autoimmune disease, or are taking immunosuppressive medications.